On December 15, the Australian Department of Health’s Therapeutic Goods Administration (TGA) announced a final decision to down-schedule certain low-dose cannabidiol (CBD) products, allowing select medicinal cannabis products to be available over the counter.

This follows the United Nations’ (UN) decision at the start of December to remove cannabis and its derivatives from Schedule IV of the international treaty governing narcotic drugs, where it was listed among addictive opioids like heroin.

With official restrictions around medicinal cannabis slowly relaxing, more Australians may be wondering how it’s different from illicit cannabis and what it’s used to treat.

– Read the entire article at Hospital Health.